Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Emricasan in NASH Fibrosis: Randomized Double-Blind Placebo-Controlled Phase 2 Trial
2015-004336-35Phase 2Completed
- Sponsor
- Conatus Pharmaceuticals Inc.
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in metabolic dysfunction-associated steatohepatitis (MASH) comparing Emricasan with Placebo (2 arms). Started Mar 2016; status: completed.
02
Drugs
emricasan
03
Conditions
metabolic dysfunction-associated steatohepatitis (MASH)
Beyond the preview
Go deeper on 2015-004336-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004336-35.